GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Almeda Ventures LP (XTAE:AMDA) » Definitions » Insider Ownership

Almeda Ventures LP (XTAE:AMDA) Insider Ownership : 0.00 % (As of May. 11, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Almeda Ventures LP Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Almeda Ventures LP's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Almeda Ventures LP's Institutional Ownership is 0.09%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Almeda Ventures LP's Float Percentage Of Total Shares Outstanding is 0.00%.


Almeda Ventures LP Insider Ownership Historical Data

The historical data trend for Almeda Ventures LP's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almeda Ventures LP Insider Ownership Chart

Almeda Ventures LP Annual Data
Trend
Insider Ownership

Almeda Ventures LP Semi-Annual Data
Insider Ownership

Almeda Ventures LP Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Almeda Ventures LP Business Description

Traded in Other Exchanges
N/A
Address
141 Menachem Begin Street, Azrieli Center, Triangle Tower, 45th Floor, Tel Aviv, ISR, 67023
Almeda Ventures LP is a life science research and development company. The company invests in Medical devices and Digital health businesses. Its portfolio includes BioProtect which developed a proprietary technology platform for biodegradable balloons. The technology suits a range of clinical applications including spacing for radiation oncology protection, and general surgery. TailorMed technology improves the financial performance of healthcare providers and reduces financial hardship for patients.

Almeda Ventures LP Headlines

No Headlines